Table of Content

1 PD-1 and PD-L1 Inhibitors Market Overview
1.1 Product Overview and Scope of PD-1 and PD-L1 Inhibitors
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 Global PD-1 and PD-L1 Inhibitors Market Value by Application: (2024-2034)
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-1 and PD-L1 Inhibitors Revenue 2018-2034
1.4.2 Global PD-1 and PD-L1 Inhibitors Sales 2018-2034
1.4.3 Global PD-1 and PD-L1 Inhibitors Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 PD-1 and PD-L1 Inhibitors Market Competition by Manufacturers
2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2018-2023)
2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturers (2018-2023)
2.4 Global PD-1 and PD-L1 Inhibitors Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of PD-1 and PD-L1 Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PD-1 and PD-L1 Inhibitors, Product Type & Application
2.7 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
2.7.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue
2.7.3 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PD-1 and PD-L1 Inhibitors Retrospective Market Scenario by Region
3.1 Global PD-1 and PD-L1 Inhibitors Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global PD-1 and PD-L1 Inhibitors Global PD-1 and PD-L1 Inhibitors Sales by Region: 2018-2034
3.2.1 Global PD-1 and PD-L1 Inhibitors Sales by Region: 2018-2023
3.2.2 Global PD-1 and PD-L1 Inhibitors Sales by Region: 2024-2034
3.3 Global PD-1 and PD-L1 Inhibitors Global PD-1 and PD-L1 Inhibitors Revenue by Region: 2018-2034
3.3.1 Global PD-1 and PD-L1 Inhibitors Revenue by Region: 2018-2023
3.3.2 Global PD-1 and PD-L1 Inhibitors Revenue by Region: 2024-2034
3.4 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.4.1 North America PD-1 and PD-L1 Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2034)
3.4.3 North America PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.5.1 Europe PD-1 and PD-L1 Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2018-2034)
3.5.3 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific PD-1 and PD-L1 Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Country (2018-2034)
3.6.3 Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.7.1 Latin America PD-1 and PD-L1 Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2034)
3.7.3 Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2018-2034)
3.8.3 Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2018-2034)
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2018-2023)
4.1.2 Global PD-1 and PD-L1 Inhibitors Sales by Type (2024-2034)
4.1.3 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2018-2034)
4.2 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2018-2034)
4.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2018-2023)
4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2024-2034)
4.2.3 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2018-2034)
4.3 Global PD-1 and PD-L1 Inhibitors Price by Type (2018-2034)
5 Segment by Application
5.1 Global PD-1 and PD-L1 Inhibitors Sales by Application (2018-2034)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Application (2018-2023)
5.1.2 Global PD-1 and PD-L1 Inhibitors Sales by Application (2024-2034)
5.1.3 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2018-2034)
5.2 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2018-2034)
5.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2018-2023)
5.2.2 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2024-2034)
5.2.3 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2018-2034)
5.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PD-1 and PD-L1 Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche PD-1 and PD-L1 Inhibitors Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Ono Pharmaceutical
6.5.1 Ono Pharmaceutical Corporation Information
6.5.2 Ono Pharmaceutical Description and Business Overview
6.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolio
6.5.5 Ono Pharmaceutical Recent Developments/Updates
6.6 Regeneron
6.6.1 Regeneron Corporation Information
6.6.2 Regeneron Description and Business Overview
6.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Regeneron PD-1 and PD-L1 Inhibitors Product Portfolio
6.6.5 Regeneron Recent Developments/Updates
6.7 Innovent
6.6.1 Innovent Corporation Information
6.6.2 Innovent Description and Business Overview
6.6.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Innovent PD-1 and PD-L1 Inhibitors Product Portfolio
6.7.5 Innovent Recent Developments/Updates
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Corporation Information
6.8.2 Hengrui Medicine Description and Business Overview
6.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolio
6.8.5 Hengrui Medicine Recent Developments/Updates
6.9 Junshi Biosciences
6.9.1 Junshi Biosciences Corporation Information
6.9.2 Junshi Biosciences Description and Business Overview
6.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolio
6.9.5 Junshi Biosciences Recent Developments/Updates
6.10 Merck KGaA
6.10.1 Merck KGaA Corporation Information
6.10.2 Merck KGaA Description and Business Overview
6.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolio
6.10.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PD-1 and PD-L1 Inhibitors Industry Chain Analysis
7.2 PD-1 and PD-L1 Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PD-1 and PD-L1 Inhibitors Production Mode & Process
7.4 PD-1 and PD-L1 Inhibitors Sales and Marketing
7.4.1 PD-1 and PD-L1 Inhibitors Sales Channels
7.4.2 PD-1 and PD-L1 Inhibitors Distributors
7.5 PD-1 and PD-L1 Inhibitors Customers
8 PD-1 and PD-L1 Inhibitors Market Dynamics
8.1 PD-1 and PD-L1 Inhibitors Industry Trends
8.2 PD-1 and PD-L1 Inhibitors Market Drivers
8.3 PD-1 and PD-L1 Inhibitors Market Challenges
8.4 PD-1 and PD-L1 Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global PD-1 and PD-L1 Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global PD-1 and PD-L1 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global PD-1 and PD-L1 Inhibitors Sales (L) of Key Manufacturers (2018-2023)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PD-1 and PD-L1 Inhibitors Average Price (USD/ml) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PD-1 and PD-L1 Inhibitors, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of PD-1 and PD-L1 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PD-1 and PD-L1 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of PD-1 and PD-L1 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global PD-1 and PD-L1 Inhibitors Sales by Region (2018-2023) & (L)
Table 18. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2018-2023)
Table 19. Global PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (L)
Table 20. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2024-2034)
Table 21. Global PD-1 and PD-L1 Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2018-2023)
Table 23. Global PD-1 and PD-L1 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2024-2034)
Table 25. North America PD-1 and PD-L1 Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2023) & (L)
Table 27. North America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 28. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe PD-1 and PD-L1 Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2018-2023) & (L)
Table 32. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 33. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2018-2023) & (L)
Table 37. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (L)
Table 38. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2023) & (L)
Table 42. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 43. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2018-2023) & (L)
Table 47. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 48. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2018-2023)
Table 51. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2024-2034)
Table 52. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2018-2023)
Table 53. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2024-2034)
Table 54. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Type (2024-2034)
Table 56. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2018-2023)
Table 57. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2024-2034)
Table 58. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2018-2023)
Table 59. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2024-2034)
Table 60. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2018-2023)
Table 61. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2024-2034)
Table 62. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2018-2023)
Table 63. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2024-2034)
Table 64. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Application (2024-2034)
Table 66. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2018-2023)
Table 67. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2024-2034)
Table 68. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2018-2023)
Table 69. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 73. Merck PD-1 and PD-L1 Inhibitors Product
Table 74. Merck Recent Developments/Updates
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 78. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 83. Roche PD-1 and PD-L1 Inhibitors Product
Table 84. Roche Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 88. AstraZeneca PD-1 and PD-L1 Inhibitors Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Ono Pharmaceutical Corporation Information
Table 91. Ono Pharmaceutical Description and Business Overview
Table 92. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 93. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product
Table 94. Ono Pharmaceutical Recent Developments/Updates
Table 95. Regeneron Corporation Information
Table 96. Regeneron Description and Business Overview
Table 97. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 98. Regeneron PD-1 and PD-L1 Inhibitors Product
Table 99. Regeneron Recent Developments/Updates
Table 100. Innovent Corporation Information
Table 101. Innovent Description and Business Overview
Table 102. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 103. Innovent PD-1 and PD-L1 Inhibitors Product
Table 104. Innovent Recent Developments/Updates
Table 105. Hengrui Medicine Corporation Information
Table 106. Hengrui Medicine Description and Business Overview
Table 107. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 108. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product
Table 109. Hengrui Medicine Recent Developments/Updates
Table 110. Junshi Biosciences Corporation Information
Table 111. Junshi Biosciences Description and Business Overview
Table 112. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 113. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product
Table 114. Junshi Biosciences Recent Developments/Updates
Table 115. Merck KGaA Corporation Information
Table 116. Merck KGaA Description and Business Overview
Table 117. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2023)
Table 118. Merck KGaA PD-1 and PD-L1 Inhibitors Product
Table 119. Merck KGaA Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. PD-1 and PD-L1 Inhibitors Distributors List
Table 123. PD-1 and PD-L1 Inhibitors Customers List
Table 124. PD-1 and PD-L1 Inhibitors Market Trends
Table 125. PD-1 and PD-L1 Inhibitors Market Drivers
Table 126. PD-1 and PD-L1 Inhibitors Market Challenges
Table 127. PD-1 and PD-L1 Inhibitors Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PD-1 and PD-L1 Inhibitors
Figure 2. Global PD-1 and PD-L1 Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global PD-1 and PD-L1 Inhibitors Market Share by Type in 2024 & 2034
Figure 4. PD-1 Inhibitors Product Picture
Figure 5. PD-L1 Inhibitors Product Picture
Figure 6. Global PD-1 and PD-L1 Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global PD-1 and PD-L1 Inhibitors Market Share by Application in 2024 & 2034
Figure 8. Solid Tumors
Figure 9. Blood-related Tumors
Figure 10. Global PD-1 and PD-L1 Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global PD-1 and PD-L1 Inhibitors Market Size (2018-2034) & (US$ Million)
Figure 12. Global PD-1 and PD-L1 Inhibitors Sales (2018-2034) & (L)
Figure 13. Global PD-1 and PD-L1 Inhibitors Average Price (USD/ml) & (2018-2034)
Figure 14. PD-1 and PD-L1 Inhibitors Report Years Considered
Figure 15. PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers in 2024
Figure 16. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest PD-1 and PD-L1 Inhibitors Players: Market Share by Revenue in 2024
Figure 18. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global PD-1 and PD-L1 Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2018-2034)
Figure 21. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2018-2034)
Figure 22. U.S. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2018-2034)
Figure 25. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2018-2034)
Figure 26. Germany PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2018-2034)
Figure 33. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2018-2034)
Figure 44. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2018-2034)
Figure 45. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2018-2034)
Figure 50. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of PD-1 and PD-L1 Inhibitors by Type (2018-2034)
Figure 54. Global Revenue Market Share of PD-1 and PD-L1 Inhibitors by Type (2018-2034)
Figure 55. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2018-2034)
Figure 56. Global Sales Market Share of PD-1 and PD-L1 Inhibitors by Application (2018-2034)
Figure 57. Global Revenue Market Share of PD-1 and PD-L1 Inhibitors by Application (2018-2034)
Figure 58. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2018-2034)
Figure 59. PD-1 and PD-L1 Inhibitors Value Chain
Figure 60. PD-1 and PD-L1 Inhibitors Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed